| Sign In to gain access to subscriptions and/or personal tools. |
Serum uric acid levels of patients with multiple sclerosis and other neurological diseasesDepartment of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, Guangdong Province, People's Republic of China
Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, Guangdong Province, People's Republic of China
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center of Sun Yat-Sen University, 54 Xianlie Road, Guangzhou 510060, Guangdong Province, People's Republic of China
Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, Guangdong Province, People's Republic of China
Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, Guangdong Province, People's Republic of China
Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, Guangdong Province, People's Republic of China, huxueqiangzssy{at}yahoo.com.cn
Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, Guangdong Province, People's Republic of China
Department of Neurology, The First Affiliated Hospital of Sun Yat-Sen University, 89 Zhongshaner Road, Guangzhou 510080, Guangdong Province, People's Republic of China The serum uric acid (UA) levels were measured in 112 patients with multiple sclerosis (MS) and 794 patients with different types of other neurological diseases (OND) or healthy control group. Serum UA levels, along with relevant clinical parameters of MS and OND, were also investigated. MS patients had significantly lower UA levels than those with transient ischemia attack (344.6 ± 130.6 µmol/L, P = 0.000), cerebral hemorrhage (311.9 ± 104.7 µmol/L, P = 0.000), cerebral infarction (291.3 ± 101.6 µmol/L, P = 0.014) and the healthy control group (312.1 ± 92.8 µmol/L, P = 0.000). MS patients had significantly higher serum UA levels than those with cryptococcus meningitis or meningoencephalitis (178.9 ± 107.0 µmol/L, P = 0.000) and tuberculous meningitis or meningoencephalitis patients (175.7 ± 99.9 µmol/L, P = 0.000). There were no significant differences in UA levels between patients with MS and those with facial neuritis, viral meningitis or encephalitis, pulmonary tuberculosis, polymyositis or dermatomyositis, myasthenia gravis, subarachnoid hemorrhage, migraine, Guillain—Barre syndrome and myelitis. In addition, UA levels were independently correlated with gender and duration of MS, but neither with MRI activity, disability nor subtypes of the disease in MS patients. Our data suggest that UA has two biphasic functions: neuroprotective and injurious. Our studies may help physicians to deal with conditions having abnormal UA levels. Multiple Sclerosis 2008; 14: 188—196. http://msj.sagepub.com
Key Words: multiple sclerosis • neuroprotection • other neurological diseases • treatment • uric acid
This version was published on March
1, 2008 Multiple Sclerosis, Vol. 14, No. 2,
188-196 (2008) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
Sign In to gain access to subscriptions and/or personal tools.
